Sandhya Prashad, MD

Sandhya Prashad, MD is a board-certified psychiatrist specializing in interventional modalities for treatment resistant disorders with a particular interest and expertise in ketamine therapy. She completed both medical school and psychiatry residency at Baylor College of Medicine. She has been in private practice in the Houston area since 2011 and has been utilizing intravenous ketamine since 2016. Dr Prashad has personally administered over 20,000 treatments with ketamine or esketamine. In addition to treatment with ketamine and esketamine, Dr. Prashad also offers deep TMS and ketamine assisted psychotherapy in her practice. She is particularly interested in combining treatment modalities to improve response to treatment. 

Dr. Prashad is involved on an international level with furthering awareness and education regarding the safe and effective use of ketamine. She is a founder and the current president of the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3, www.ASKP.org) Dr. Prashad presents frequently on a national level both to the public and to other physicians regarding the use of ketamine for psychiatric disorders. She also serves on several advisory panels for ketamine related research and her private practice is a site for a PCORI funded trial comparing IV ketamine to intranasal spravato.